4.6 Article

Cardamonin exerts anti-gastric cancer activity via inhibiting LncRNA-PVT1-STAT3 axis

Journal

BIOSCIENCE REPORTS
Volume 39, Issue -, Pages -

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BSR20190357

Keywords

-

Funding

  1. 333 Project for High-level Talents Cultivation of Jiangsu Province [BRA2017153]

Ask authors/readers for more resources

Background: Gastric cancer is one of the most commonly diagnosed cancers each year, and it remains the third leading cause of cancer death in the world. The clinicopathologic characteristics differ among regions, so epigenetic changes play a key role in gastric carcinogenesis. Methods: In the present study, we first demonstrate that cardamonin, a natural production of chalcone, is an anti-gastric cancer agent in pre-clinical evaluation. Results: Cardamonin inhibited proliferation and migration, induced apoptosis in gastric cancer cells. It could reduce the expression of apoptosis-related and migration-related genes and proteins. The constant activation of STAT3 (signal transducer and activator of transcription 3) signal is a major intrinsic signal for cancer inflammation. It regulates cellular proliferation, cell cycle, and migration that are critical for cancer procession. Cardamonin could effectively down-regulate p-STAT3 and abolish activation of STAT3 through inhibiting the expression of LncRNA-PVT1. Conclusion: The present study revealed that cardamonin is a potential natural source of anti-gastric cancer drugs via epigenetic mechanism to inhibit LncRNA-PVT1-STAT3 axis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ

Meiyuan Yang, Xiaoli Tang, Zheng Wang, Xiaoqing Wu, Dong Tang, Daorong Wang

BIOSCIENCE REPORTS (2019)

Article Biochemistry & Molecular Biology

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study

Zheng Wang, Xiaoli Tang, Xiaoqing Wu, Meiyuan Yang, Daorong Wang

BIOSCIENCE REPORTS (2019)

Review Surgery

The Application of Enhanced Recovery After Surgery (ERAS) for Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis

Jiajie Zhou, Rui Du, Liuhua Wang, Feng Wang, Dongliang Li, Guifan Tong, Wei Wang, Xu Ding, Daorong Wang

Summary: This study systematically evaluated the effectiveness and safety of the ERAS pathway in bariatric surgery, finding that ERAS intervention significantly reduced the length of hospital stay and incidence of postoperative nausea and vomiting, without significant differences in other outcomes compared to standard care.

OBESITY SURGERY (2021)

Article Oncology

Galectin-1 binds GRP78 to promote the proliferation and metastasis of gastric cancer

Qi Zhang, Muhammad Ali, Yang Wang, Qian-Nan Sun, Xiao-Dong Zhu, Dong Tang, Wei Wang, Cang-Yuan Zhang, Hai-Hua Zhou, Dao-Rong Wang

Summary: The present study reveals that galectin-1 (Gal-1) and glucose-regulated protein 78 (GRP78) play important roles in the development of malignant gastric cancer (GC). High levels of Gal-1 and GRP78 expression are associated with poor prognosis in GC patients. Gal-1 interacts with GRP78 to facilitate the proliferation, migration, and invasion of GC, thus accelerating its progression.

INTERNATIONAL JOURNAL OF ONCOLOGY (2022)

Article Surgery

A retrospective study of post-operative complications and cost analysis in robotic rectal resection versus laparoscopic rectal resection

Muhammad Ali, Xiaodong Zhu, Yang Wang, Jianyue Ding, Qi Zhang, Qiannan Sun, Shantanu Baral, Daorong Wang

Summary: This study compared the short-term outcomes of robotic surgery and laparoscopic surgery in treating rectal cancer. The results showed that robotic surgery had better performance in terms of Clavien-Dindo classification, sepsis, and harvested lymph nodes, but it was also associated with higher cost.

FRONTIERS IN SURGERY (2022)

Letter Surgery

Treatment of a recurrent duodenal tumor after esophageal cancer surgery

Jin Ji, Muhammad Ali, Mingrui Jiang, Daorong Wang

ASIAN JOURNAL OF SURGERY (2023)

Letter Surgery

Laparoscopic right hemicolectomy and supportive treatment for rectal tumor with the sequelae of loose stool: A case report

Jianyue Ding, Muhammad Ali, Fanyu Zhao, Daorong Wang

ASIAN JOURNAL OF SURGERY (2023)

Article Oncology

ATF4 Transcriptionally Activates SHH to Promote Proliferation, Invasion, and Migration of Gastric Cancer Cells

Yang Wang, Muhammad Ali, Qi Zhang, Qiannan Sun, Jun Ren, Wei Wang, Dong Tang, Daorong Wang

Summary: Gastric cancer (GC) is the third leading cause of cancer-related death worldwide. We discovered that the transcription factor ATF4 is significantly upregulated in GC and plays a crucial role in promoting the proliferation and invasion of GC cells through activating the Sonic Hedgehog pathway. Understanding the mechanism of ATF4 in gastric cancer may provide new insights for developing targeted therapies.

CANCERS (2023)

Article Surgery

Benefits of minimally invasive surgery for rectal cancer in older adults compared with younger adults: a retrospective study

Muhammad Ali, Yang Wang, Wenhao Yu, Shantanu Baral, Ren Jun, Daorong Wang

Summary: Randomized research showed that robotic surgery is safe and beneficial for oncological purposes in the short term. This study aimed to investigate if older adults derive greater benefits from robotic surgery compared to younger adults in terms of short-term outcomes. A retrospective analysis was performed on all rectal cancer patients aged 70 years and above (older adults) and below 70 years (younger adults) who underwent resection from 2019 to 2022. Short-term post-operative outcomes, including bowel movement, hospital stay duration, sepsis, and lymph node harvest, were evaluated based on age. The key outcomes assessed were complications and grades III-IV according to the Clavien-Dindo scale. Of the 298 individuals treated for rectal cancer, 108 (36.6%) were older adults and 190 (63.4%) were younger adults. Among older adults, 45 (41.6%) underwent robotic surgery while 63 (58.3%) underwent laparoscopic surgery. Among younger adults, 85 (44.7%) underwent robotic surgery while 105 (55.2%) underwent laparoscopic surgery. The analysis demonstrated a significant difference (P < 0.05) in the Clavien-Dindo grading system, with a higher proportion of grade III-IV patients in the laparoscopic surgery group compared to the robotic surgery group. Both younger and older individuals experienced different benefits from robotic surgery compared to laparoscopic surgery in terms of major post-operative complications.

JOURNAL OF ROBOTIC SURGERY (2023)

No Data Available